Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Karlin

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|October 10, 1984
Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding siteP N Kao, A J Dwork, R R Kaldany, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancerA Y Bedikian, J R Stroehlein, D A Karlin, et al.
Cancer Treatment Reports|August 1, 1982
Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreasD A Karlin, J R Stroehlein, R W Bennetts, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancerM Valdivieso, J R Stroehlein, A Y Bedikian, et al.
Cancer|November 1, 1980
5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreasF P Smith, D F Hoth, B Levin, et al.
Scientific Reports|April 1, 2016
Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editingYuichiro Miyaoka, Jennifer R Berman, Samantha B Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancerJohn R Eckardt, Dimitri L Bentsion, Oleg N Lipatov, et al.
Gastroenterology|May 1, 1984
Comparison of colon cleansing methods in preparation for colonoscopyJ A DiPalma, C E Brady, D L Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trialDavid R Spigel, Peter M Townley, David M Waterhouse, et al.
Nature Biotechnology|May 6, 2003
Multiplexed genotyping with sequence-tagged molecular inversion probesPaul Hardenbol, Johan Banér, Maneesh Jain, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|October 10, 1984
Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding siteP N Kao, A J Dwork, R R Kaldany, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancerA Y Bedikian, J R Stroehlein, D A Karlin, et al.
Cancer Treatment Reports|August 1, 1982
Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreasD A Karlin, J R Stroehlein, R W Bennetts, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancerM Valdivieso, J R Stroehlein, A Y Bedikian, et al.
Cancer|November 1, 1980
5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreasF P Smith, D F Hoth, B Levin, et al.
Scientific Reports|April 1, 2016
Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editingYuichiro Miyaoka, Jennifer R Berman, Samantha B Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancerJohn R Eckardt, Dimitri L Bentsion, Oleg N Lipatov, et al.
Gastroenterology|May 1, 1984
Comparison of colon cleansing methods in preparation for colonoscopyJ A DiPalma, C E Brady, D L Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trialDavid R Spigel, Peter M Townley, David M Waterhouse, et al.
Nature Biotechnology|May 6, 2003
Multiplexed genotyping with sequence-tagged molecular inversion probesPaul Hardenbol, Johan Banér, Maneesh Jain, et al.
Pageof 10